Tenaya Therapeutics

Price & Volume

Stats

52W Range	$0.86-$7.01
Market Cap	$87.9M
Shares Short	12M

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$1.44

News

Yahoo Finance • last year

Tenaya Therapeutics to Participate at the 35th Annual Piper Sandler Healthcare Conference

Yahoo Finance • last year

Tenaya Therapeutics Announces FDA Clearance to Begin Clinical Testing of TN-401 Gene Therapy for the Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy

Yahoo Finance • last year

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

Yahoo Finance • last year

Tenaya Therapeutics Doses First Patient in the MyPeak-1™ Phase 1b Clinical Trial of TN-201 for the Treatment of MYBPC3-Associated Hypertrophic Cardiomyopathy

About

CEO	Mr. Faraz Ali M.B.A.
Address	171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	140